-
1
-
-
0034632818
-
Benefits of bad telomeres
-
Hanahan D. Benefits of bad telomeres. Nature 2000; 406:573-574.
-
(2000)
Nature
, vol.406
, pp. 573-574
-
-
Hanahan, D.1
-
2
-
-
0025472467
-
Telomeres, telomerase and senescence
-
Greider CW. Telomeres, telomerase and senescence. Bioessays 1990; 12:363-369.
-
(1990)
Bioessays
, vol.12
, pp. 363-369
-
-
Greider, C.W.1
-
3
-
-
24944460598
-
Shelterin: The protein complex that shapes and safeguards human telomeres
-
De Lange T. Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-2110.
-
(2005)
Genes Dev
, vol.19
, pp. 2100-2110
-
-
De Lange, T.1
-
5
-
-
3042824901
-
Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin
-
Alves DS, Perez-Fons L, Estepa A, Micol V. Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin. Biochem Pharmacol 2004; 68:549-561.
-
(2004)
Biochem Pharmacol
, vol.68
, pp. 549-561
-
-
Alves, D.S.1
Perez-Fons, L.2
Estepa, A.3
Micol, V.4
-
6
-
-
0026608237
-
Interaction of the dye ethidium bromide with DNA containing guanine repeats
-
Guo Q, Lu M, Marky LA, Kallenbach NR. Interaction of the dye ethidium bromide with DNA containing guanine repeats. Biochemistry 1992; 31:2451-2455.
-
(1992)
Biochemistry
, vol.31
, pp. 2451-2455
-
-
Guo, Q.1
Lu, M.2
Marky, L.A.3
Kallenbach, N.R.4
-
7
-
-
0033524027
-
Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: Structure-activity relationships
-
Read MA, Wood AA, Harrison JR, Gowan SM, Kelland LR, Dosanjh HS, et al. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: Structure-activity relationships. J Med Chem 1999; 42:4538-4546.
-
(1999)
J Med Chem
, vol.42
, pp. 4538-4546
-
-
Read, M.A.1
Wood, A.A.2
Harrison, J.R.3
Gowan, S.M.4
Kelland, L.R.5
Dosanjh, H.S.6
-
8
-
-
18044391665
-
Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics - Current status and future prospects
-
Kelland LR. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics - current status and future prospects. Eur J Cancer 2005; 41:971-979.
-
(2005)
Eur J Cancer
, vol.41
, pp. 971-979
-
-
Kelland, L.R.1
-
9
-
-
0036562687
-
Telomere maintenance as a target for anticancer drug discovery
-
Neidle S, Parkinson G. Telomere maintenance as a target for anticancer drug discovery. Nat Rev Drug Discov 2002; 1:383-393.
-
(2002)
Nat Rev Drug Discov
, vol.1
, pp. 383-393
-
-
Neidle, S.1
Parkinson, G.2
-
10
-
-
0037082423
-
Natural and pharmacological regulation of telomerase
-
Mergny JL, Riou JF, Mailliet P, Teulade-Fichou MP, Gilson E. Natural and pharmacological regulation of telomerase. Nucleic Acids Res 2002; 30:839-865.
-
(2002)
Nucleic Acids Res
, vol.30
, pp. 839-865
-
-
Mergny, J.L.1
Riou, J.F.2
Mailliet, P.3
Teulade-Fichou, M.P.4
Gilson, E.5
-
11
-
-
0035357574
-
Recent developments in the field of antitumour anthracyclines
-
Monneret C. Recent developments in the field of antitumour anthracyclines. Eur J Med Chem 2001; 36:483-493.
-
(2001)
Eur J Med Chem
, vol.36
, pp. 483-493
-
-
Monneret, C.1
-
13
-
-
0032514479
-
1, 4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase
-
Perry PJ, Gowan SM, Reszka AP, Polucci P, Jenkins TC, Kelland LR, et al. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. J Med Chem 1998; 41:3253-3260.
-
(1998)
J Med Chem
, vol.41
, pp. 3253-3260
-
-
Perry, P.J.1
Gowan, S.M.2
Reszka, A.P.3
Polucci, P.4
Jenkins, T.C.5
Kelland, L.R.6
-
14
-
-
0033566092
-
2, 7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase
-
Perry PJ, Read MA, Davies RT, Gowan SM, Reszka AP, Wood AA, et al. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. J Med Chem 1999; 42:2679-2684.
-
(1999)
J Med Chem
, vol.42
, pp. 2679-2684
-
-
Perry, P.J.1
Read, M.A.2
Davies, R.T.3
Gowan, S.M.4
Reszka, A.P.5
Wood, A.A.6
-
15
-
-
7844223625
-
Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones
-
Perry PJ, Reszka AP, Wood AA, Read MA, Gowan SM, Dosanjh HS, et al. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10- diones. J Med Chem 1998; 41:4873-4884.
-
(1998)
J Med Chem
, vol.41
, pp. 4873-4884
-
-
Perry, P.J.1
Reszka, A.P.2
Wood, A.A.3
Read, M.A.4
Gowan, S.M.5
Dosanjh, H.S.6
-
16
-
-
31544446381
-
Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation
-
Moore MJ, Schultes CM, Cuesta J, Cuenca F, Gunaratnam M, Tanious FA, et al. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J Med Chem 2006; 49:582-599.
-
(2006)
J Med Chem
, vol.49
, pp. 582-599
-
-
Moore, M.J.1
Schultes, C.M.2
Cuesta, J.3
Cuenca, F.4
Gunaratnam, M.5
Tanious, F.A.6
-
17
-
-
16844375686
-
Chemical approaches to the discovery and development of cancer therapies
-
Neidle S, Thurston DE. Chemical approaches to the discovery and development of cancer therapies. Nat Rev Cancer 2005; 5:285-296.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 285-296
-
-
Neidle, S.1
Thurston, D.E.2
-
18
-
-
0023922254
-
Synthesis, molecular modeling, DNA binding, and antitumor properties of some substituted amidoanthraquinones
-
Collier DA, Neidle S. Synthesis, molecular modeling, DNA binding, and antitumor properties of some substituted amidoanthraquinones. J Med Chem 1988; 31:847-857.
-
(1988)
J Med Chem
, vol.31
, pp. 847-857
-
-
Collier, D.A.1
Neidle, S.2
-
19
-
-
0026776299
-
Anthracene-9,10-diones as potential anticancer agents. Synthesis, DNA-binding, and biological studies on a series of 2,6-disubstituted derivatives
-
Agbandje M, Jenkins TC, McKenna R, Reszka AP, Neidle S. Anthracene- 9,10-diones as potential anticancer agents. Synthesis, DNA-binding, and biological studies on a series of 2,6-disubstituted derivatives. J Med Chem 1992; 35:1418-1429.
-
(1992)
J Med Chem
, vol.35
, pp. 1418-1429
-
-
Agbandje, M.1
Jenkins, T.C.2
McKenna, R.3
Reszka, A.P.4
Neidle, S.5
-
20
-
-
0030786928
-
Inhibition of human telomerase by a G-quadruplex-interactive compound
-
Sun D, Thompson B, Cathers BE, Salazar M, Kerwin SM, Trent JO, et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 1997; 40:2113-2116.
-
(1997)
J Med Chem
, vol.40
, pp. 2113-2116
-
-
Sun, D.1
Thompson, B.2
Cathers, B.E.3
Salazar, M.4
Kerwin, S.M.5
Trent, J.O.6
-
21
-
-
0035942270
-
Structure-based design of selective and potent G quadruplexmediated telomerase inhibitors
-
Read M, Harrison RJ, Romagnoli B, Tanious FA, Gowan SH, Reszka AP, et al. Structure-based design of selective and potent G quadruplexmediated telomerase inhibitors. Proc Natl Acad Sci U S A 2001; 98:4844-4849.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 4844-4849
-
-
Read, M.1
Harrison, R.J.2
Romagnoli, B.3
Tanious, F.A.4
Gowan, S.H.5
Reszka, A.P.6
-
22
-
-
38049007426
-
Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2, 6 and 2,7 bis-substituted anthracenedione derivatives
-
Zagotto G, Sissi C, Moro S, Dal Ben D, Parkinson GN, Fox KR, et al. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives. Bioorg Med Chem 2008; 16:354-361.
-
(2008)
Bioorg Med Chem
, vol.16
, pp. 354-361
-
-
Zagotto, G.1
Sissi, C.2
Moro, S.3
Dal Ben, D.4
Parkinson, G.N.5
Fox, K.R.6
-
23
-
-
33846954426
-
Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones
-
Huang HS, Chen IB, Huang KF, Lu WC, Shieh FY, Huang YY, et al. Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones. Chem Pharm Bull (Tokyo) 2007; 55:284-292.
-
(2007)
Chem Pharm Bull (Tokyo)
, vol.55
, pp. 284-292
-
-
Huang, H.S.1
Chen, I.B.2
Huang, K.F.3
Lu, W.C.4
Shieh, F.Y.5
Huang, Y.Y.6
-
24
-
-
13444311877
-
Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones
-
Huang HS, Chou CL, Guo CL, Yuan CL, Lu YC, Shieh FY, et al. Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones. Bioorg Med Chem 2005; 13:1435-1444.
-
(2005)
Bioorg Med Chem
, vol.13
, pp. 1435-1444
-
-
Huang, H.S.1
Chou, C.L.2
Guo, C.L.3
Yuan, C.L.4
Lu, Y.C.5
Shieh, F.Y.6
-
25
-
-
47549098577
-
Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives
-
Huang HS, Huang KF, Li CL, Huang YY, Chiang YH, Huang FC, et al. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives. Bioorg Med Chem 2008; 16:6976-6986.
-
(2008)
Bioorg Med Chem
, vol.16
, pp. 6976-6986
-
-
Huang, H.S.1
Huang, K.F.2
Li, C.L.3
Huang, Y.Y.4
Chiang, Y.H.5
Huang, F.C.6
-
26
-
-
33645550875
-
Synthesis and antitumor evaluation of symmetrical 1,5- diamidoanthraquinone derivatives as compared to their disubstituted homologues
-
Huang HS, Chiu HF, Tao CW, Chen IB. Synthesis and antitumor evaluation of symmetrical 1,5-diamidoanthraquinone derivatives as compared to their disubstituted homologues. Chem Pharm Bull (Tokyo) 2006; 54:458-464.
-
(2006)
Chem Pharm Bull (Tokyo)
, vol.54
, pp. 458-464
-
-
Huang, H.S.1
Chiu, H.F.2
Tao, C.W.3
Chen, I.B.4
-
27
-
-
0038155211
-
Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone
-
Huang HS, Chiou JF, Fong Y, Hou CC, Lu YC, Wang JY, et al. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone. J Med Chem 2003; 46:3300-3307.
-
(2003)
J Med Chem
, vol.46
, pp. 3300-3307
-
-
Huang, H.S.1
Chiou, J.F.2
Fong, Y.3
Hou, C.C.4
Lu, Y.C.5
Wang, J.Y.6
-
28
-
-
2342568938
-
Synthesis and evaluation of analogues of 10H-indolo[ 3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase
-
Guyen B, Schultes CM, Hazel P, Mann J, Neidle S. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. Org Biomol Chem 2004; 2:981-988.
-
(2004)
Org Biomol Chem
, vol.2
, pp. 981-988
-
-
Guyen, B.1
Schultes, C.M.2
Hazel, P.3
Mann, J.4
Neidle, S.5
-
30
-
-
0037427245
-
Structure of the first parallel DNA quadruplex-drug complex
-
Clark GR, Pytel PD, Squire CJ, Neidle S. Structure of the first parallel DNA quadruplex-drug complex. J Am Chem Soc 2003; 125:4066-4067.
-
(2003)
J Am Chem Soc
, vol.125
, pp. 4066-4067
-
-
Clark, G.R.1
Pytel, P.D.2
Squire, C.J.3
Neidle, S.4
-
31
-
-
0032697230
-
Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif
-
Perry PJ, Gowan SM, Read MA, Kelland LR, Neidle S. Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif. Anticancer Drug Des 1999; 14:373-382.
-
(1999)
Anticancer Drug des
, vol.14
, pp. 373-382
-
-
Perry, P.J.1
Gowan, S.M.2
Read, M.A.3
Kelland, L.R.4
Neidle, S.5
-
33
-
-
40649094294
-
A concise paradigm for the construction of amide linker of 2,7-diamidoanthraquinone derivatives as potential telomerase inhibitors
-
Huang H, Lin J, Huang K, Li C. A concise paradigm for the construction of amide linker of 2,7-diamidoanthraquinone derivatives as potential telomerase inhibitors. Taiwan Pharm J 2007; 59:179-187.
-
(2007)
Taiwan Pharm J
, vol.59
, pp. 179-187
-
-
Huang, H.1
Lin, J.2
Huang, K.3
Li, C.4
-
34
-
-
0025865126
-
Anticancer drug discovery
-
Sikic BI. Anticancer drug discovery. J Natl Cancer Inst 1991; 83:738-740.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 738-740
-
-
Sikic, B.I.1
-
35
-
-
0025775062
-
Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
-
Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991; 83:757-766.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 757-766
-
-
Monks, A.1
Scudiero, D.2
Skehan, P.3
Shoemaker, R.4
Paull, K.5
Vistica, D.6
-
36
-
-
0030832842
-
The NCI anti-cancer drug screen: A smart screen to identify effectors of novel targets
-
Monks A, Scudiero DA, Johnson GS, Paull KD, Sausville EA. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anticancer Drug Des 1997; 12:533-541.
-
(1997)
Anticancer Drug des
, vol.12
, pp. 533-541
-
-
Monks, A.1
Scudiero, D.A.2
Johnson, G.S.3
Paull, K.D.4
Sausville, E.A.5
-
37
-
-
1942422761
-
Update on NCI in vitro drug screen utilities
-
Holbeck SL. Update on NCI in vitro drug screen utilities. Eur J Cancer 2004; 40:785-793.
-
(2004)
Eur J Cancer
, vol.40
, pp. 785-793
-
-
Holbeck, S.L.1
-
38
-
-
0036233675
-
Developmental Therapeutics Program at the NCI: Molecular target and drug discovery process
-
Monga M, Sausville EA. Developmental Therapeutics Program at the NCI: molecular target and drug discovery process. Leukemia 2002; 16:520-526.
-
(2002)
Leukemia
, vol.16
, pp. 520-526
-
-
Monga, M.1
Sausville, E.A.2
-
39
-
-
33749011163
-
The NCI60 human tumour cell line anticancer drug screen
-
Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006; 6:813-823.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 813-823
-
-
Shoemaker, R.H.1
-
40
-
-
20944439854
-
Elucidation of thioredoxin as a molecular target for antitumor quinols
-
Bradshaw TD, Matthews CS, Cookson J, Chew EH, Shah M, Bailey K, et al. Elucidation of thioredoxin as a molecular target for antitumor quinols. Cancer Res 2005; 65:3911-3919.
-
(2005)
Cancer Res
, vol.65
, pp. 3911-3919
-
-
Bradshaw, T.D.1
Matthews, C.S.2
Cookson, J.3
Chew, E.H.4
Shah, M.5
Bailey, K.6
-
41
-
-
4644353500
-
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: Part 1: Cellular pharmacology, in vitro and initial in vivo antitumor activity
-
Hartley JA, Spanswick VJ, Brooks N, Clingen PH, McHugh PJ, Hochhauser D, et al. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: Cellular pharmacology, in vitro and initial in vivo antitumor activity. Cancer Res 2004; 64:6693-6699.
-
(2004)
Cancer Res
, vol.64
, pp. 6693-6699
-
-
Hartley, J.A.1
Spanswick, V.J.2
Brooks, N.3
Clingen, P.H.4
McHugh, P.J.5
Hochhauser, D.6
-
42
-
-
0347624599
-
Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf
-
Goueli BS, Janknecht R. Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf. Mol Cell Biol 2004; 24:25-35.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 25-35
-
-
Goueli, B.S.1
Janknecht, R.2
-
43
-
-
0010045614
-
Extension of life-span by introduction of telomerase into normal human cells
-
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-352.
-
(1998)
Science
, vol.279
, pp. 349-352
-
-
Bodnar, A.G.1
Ouellette, M.2
Frolkis, M.3
Holt, S.E.4
Chiu, C.P.5
Morin, G.B.6
-
44
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
-
(1983)
J Immunol Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
45
-
-
0022445670
-
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability
-
Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89:271-277.
-
(1986)
J Immunol Methods
, vol.89
, pp. 271-277
-
-
Denizot, F.1
Lang, R.2
-
46
-
-
0028564951
-
Specific association of human telomerase activity with immortal cells and cancer
-
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-2015.
-
(1994)
Science
, vol.266
, pp. 2011-2015
-
-
Kim, N.W.1
Piatyszek, M.A.2
Prowse, K.R.3
Harley, C.B.4
West, M.D.5
Ho, P.L.6
-
47
-
-
0028145773
-
Phylogenetic and molecular characterization of a 23S rRNA gene positions the genus Campylobacter in the epsilon subdivision of the Proteobacteria and shows that the presence of transcribed spacers is common in Campylobacter spp
-
Trust TJ, Logan SM, Gustafson CE, Romaniuk PJ, Kim NW, Chan VL, et al. Phylogenetic and molecular characterization of a 23S rRNA gene positions the genus Campylobacter in the epsilon subdivision of the Proteobacteria and shows that the presence of transcribed spacers is common in Campylobacter spp. J Bacteriol 1994; 176:4597-4609.
-
(1994)
J Bacteriol
, vol.176
, pp. 4597-4609
-
-
Trust, T.J.1
Logan, S.M.2
Gustafson, C.E.3
Romaniuk, P.J.4
Kim, N.W.5
Chan, V.L.6
-
48
-
-
0028673260
-
Telomerase, cell immortality, and cancer
-
Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS,West MD, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994; 59:307-315.
-
(1994)
Cold Spring Harb Symp Quant Biol
, vol.59
, pp. 307-315
-
-
Harley, C.B.1
Kim, N.W.2
Prowse, K.R.3
Weinrich, S.L.4
Hirsch, K.S.5
West, M.D.6
-
49
-
-
0027014940
-
Secreted placental alkaline phosphatase as a eukaryotic reporter gene
-
Cullen BR, Malim MH. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol 1992; 216:362-368.
-
(1992)
Methods Enzymol
, vol.216
, pp. 362-368
-
-
Cullen, B.R.1
Malim, M.H.2
-
50
-
-
0024312538
-
Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm
-
Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubinstein L, et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst 1989; 81:1088-1092.
-
(1989)
J Natl Cancer Inst
, vol.81
, pp. 1088-1092
-
-
Paull, K.D.1
Shoemaker, R.H.2
Hodes, L.3
Monks, A.4
Scudiero, D.A.5
Rubinstein, L.6
-
51
-
-
0029655485
-
Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines
-
Strahl C, Blackburn EH. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 1996; 16:53-65.
-
(1996)
Mol Cell Biol
, vol.16
, pp. 53-65
-
-
Strahl, C.1
Blackburn, E.H.2
-
52
-
-
0035045477
-
Telomerase activation, cellular immortalization and cancer
-
Hahn WC, Meyerson M. Telomerase activation, cellular immortalization and cancer. Ann Med 2001; 33:123-129.
-
(2001)
Ann Med
, vol.33
, pp. 123-129
-
-
Hahn, W.C.1
Meyerson, M.2
-
53
-
-
0031010342
-
A survey of telomerase activity in human cancer
-
Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33:787-791.
-
(1997)
Eur J Cancer
, vol.33
, pp. 787-791
-
-
Shay, J.W.1
Bacchetti, S.2
-
54
-
-
0037323195
-
Stem cells, telomerase and dyskeratosis congenita
-
Mason PJ. Stem cells, telomerase and dyskeratosis congenita. Bioessays 2003; 25:126-133.
-
(2003)
Bioessays
, vol.25
, pp. 126-133
-
-
Mason, P.J.1
-
55
-
-
33745679352
-
Telomerase therapeutics for cancer: Challenges and new directions
-
Shay JW, Wright WE. Telomerase therapeutics for cancer: Challenges and new directions. Nat Rev Drug Discov 2006; 5:577-584.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 577-584
-
-
Shay, J.W.1
Wright, W.E.2
-
56
-
-
7444230327
-
Synthesis and structure- activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives
-
Huang HS, Chiu HF, Lee AL, Guo CL, Yuan CL. Synthesis and structure- activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives. Bioorg Med Chem 2004; 12:6163-6170.
-
(2004)
Bioorg Med Chem
, vol.12
, pp. 6163-6170
-
-
Huang, H.S.1
Chiu, H.F.2
Lee, A.L.3
Guo, C.L.4
Yuan, C.L.5
-
57
-
-
0034064858
-
G-quadruplexes as targets for drug design
-
Hurley LH,Wheelhouse RT, Sun D, Kerwin SM, Salazar M, Fedoroff OY, et al. G-quadruplexes as targets for drug design. Pharmacol Ther 2000; 85:141-158.
-
(2000)
Pharmacol Ther
, vol.85
, pp. 141-158
-
-
Hurley, L.H.1
Wheelhouse, R.T.2
Sun, D.3
Kerwin, S.M.4
Salazar, M.5
Fedoroff, O.Y.6
-
58
-
-
0034578478
-
G-quadruplexes as therapeutic targets
-
Neidle S, Read MA. G-quadruplexes as therapeutic targets. Biopolymers 2000; 56:195-208.
-
(2000)
Biopolymers
, vol.56
, pp. 195-208
-
-
Neidle, S.1
Read, M.A.2
-
59
-
-
34247880252
-
Induced fit conformational changes of a reversed amidine heterocycle: Optimized interactions in a DNA minor groove complex
-
Munde M, Lee M, Neidle S, Arafa R, Boykin DW, Liu Y, et al. Induced fit conformational changes of a reversed amidine heterocycle: optimized interactions in a DNA minor groove complex. J Am Chem Soc 2007; 129:5688-5698.
-
(2007)
J Am Chem Soc
, vol.129
, pp. 5688-5698
-
-
Munde, M.1
Lee, M.2
Neidle, S.3
Arafa, R.4
Boykin, D.W.5
Liu, Y.6
-
60
-
-
0025322747
-
Subsidiary hydrogen bonding of intercalated anthraquinonic anticancer drugs to DNA phosphate
-
Pohle W, Bohl M, Flemming J, Bohlig H. Subsidiary hydrogen bonding of intercalated anthraquinonic anticancer drugs to DNA phosphate. Biophys Chem 1990; 35:213-226.
-
(1990)
Biophys Chem
, vol.35
, pp. 213-226
-
-
Pohle, W.1
Bohl, M.2
Flemming, J.3
Bohlig, H.4
-
61
-
-
36048947569
-
Development of DNA-intercalatorpolyamine multi-conjugate bearing the ability of the sequence-specific RNA hydrolysis
-
Moriguchi T, Ohike T, Shinozuka K. Development of DNA- intercalatorpolyamine multi-conjugate bearing the ability of the sequence-specific RNA hydrolysis. Nucleic Acids Symp Ser (Oxf) 2006; 50:187-188.
-
(2006)
Nucleic Acids Symp ser (Oxf)
, vol.50
, pp. 187-188
-
-
Moriguchi, T.1
Ohike, T.2
Shinozuka, K.3
-
62
-
-
38049030699
-
Human telomere, oncogenic promoter and 50-UTR G-quadruplexes: Diverse higher order DNA and RNA targets for cancer therapeutics
-
Patel DJ, Phan AT, Kuryavyi V. Human telomere, oncogenic promoter and 50-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res 2007; 35:7429-7455.
-
(2007)
Nucleic Acids Res
, vol.35
, pp. 7429-7455
-
-
Patel, D.J.1
Phan, A.T.2
Kuryavyi, V.3
-
63
-
-
0036241599
-
A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity
-
Gowan SM, Harrison JR, Patterson L, Valenti M, Read MA, Neidle S, et al. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Mol Pharmacol 2002; 61:1154-1162.
-
(2002)
Mol Pharmacol
, vol.61
, pp. 1154-1162
-
-
Gowan, S.M.1
Harrison, J.R.2
Patterson, L.3
Valenti, M.4
Read, M.A.5
Neidle, S.6
-
64
-
-
34547112050
-
Mechanism of acridine-based telomerase inhibition and telomere shortening
-
Gunaratnam M, Greciano O, Martins C, Reszka AP, Schultes CM, Morjani H, et al. Mechanism of acridine-based telomerase inhibition and telomere shortening. Biochem Pharmacol 2007; 74:679-689.
-
(2007)
Biochem Pharmacol
, vol.74
, pp. 679-689
-
-
Gunaratnam, M.1
Greciano, O.2
Martins, C.3
Reszka, A.P.4
Schultes, C.M.5
Morjani, H.6
-
65
-
-
36049045013
-
Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect
-
Salvati E, Leonetti C, Rizzo A, Scarsella M, Mottolese M, Galati R, et al. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest 2007; 117:3236-3247.
-
(2007)
J Clin Invest
, vol.117
, pp. 3236-3247
-
-
Salvati, E.1
Leonetti, C.2
Rizzo, A.3
Scarsella, M.4
Mottolese, M.5
Galati, R.6
-
66
-
-
0034122135
-
G-Quadruplex DNA as a target for drug design
-
Kerwin SM. G-Quadruplex DNA as a target for drug design. Curr Pharm Des 2000; 6:441-478.
-
(2000)
Curr Pharm des
, vol.6
, pp. 441-478
-
-
Kerwin, S.M.1
-
68
-
-
0033178533
-
Stabilization of DNA triple helices by a series of mono- and disubstituted amidoanthraquinones
-
Keppler MD, Read MA, Perry PJ, Trent JO, Jenkins TC, Reszka AP, et al. Stabilization of DNA triple helices by a series of mono- and disubstituted amidoanthraquinones. Eur J Biochem 1999; 263:817-825.
-
(1999)
Eur J Biochem
, vol.263
, pp. 817-825
-
-
Keppler, M.D.1
Read, M.A.2
Perry, P.J.3
Trent, J.O.4
Jenkins, T.C.5
Reszka, A.P.6
-
69
-
-
33845355611
-
Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: Potential for development of tumor-selective N-oxides
-
Pors K, Shnyder SD, Teesdale-Spittle PH, Hartley JA, Zloh M, Searcey M, et al. Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: potential for development of tumor-selective N-oxides. J Med Chem 2006; 49:7013-7023.
-
(2006)
J Med Chem
, vol.49
, pp. 7013-7023
-
-
Pors, K.1
Shnyder, S.D.2
Teesdale-Spittle, P.H.3
Hartley, J.A.4
Zloh, M.5
Searcey, M.6
-
70
-
-
24944477680
-
Synthesis and antitumor activity of 1,8-diaminoanthraquinone derivatives
-
Huang HS, Chiu HF, Lu WC, Yuan CL. Synthesis and antitumor activity of 1,8-diaminoanthraquinone derivatives. Chem Pharm Bull (Tokyo) 2005; 53:1136-1139.
-
(2005)
Chem Pharm Bull (Tokyo)
, vol.53
, pp. 1136-1139
-
-
Huang, H.S.1
Chiu, H.F.2
Lu, W.C.3
Yuan, C.L.4
|